These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27647218)

  • 41. NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans.
    de la Salle S; Shah D; Choueiry J; Bowers H; McIntosh J; Ilivitsky V; Knott V
    Front Pharmacol; 2019; 10():455. PubMed ID: 31139075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Schizophrenia-like phenotypes in mice with NMDA receptor ablation in intralaminar thalamic nucleus cells and gene therapy-based reversal in adults.
    Yasuda K; Hayashi Y; Yoshida T; Kashiwagi M; Nakagawa N; Michikawa T; Tanaka M; Ando R; Huang A; Hosoya T; McHugh TJ; Kuwahara M; Itohara S
    Transl Psychiatry; 2017 Feb; 7(2):e1047. PubMed ID: 28244984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.
    Ehrlichman RS; Gandal MJ; Maxwell CR; Lazarewicz MT; Finkel LH; Contreras D; Turetsky BI; Siegel SJ
    Neuroscience; 2009 Jan; 158(2):705-12. PubMed ID: 19015010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study.
    Rowland LM; Bustillo JR; Mullins PG; Jung RE; Lenroot R; Landgraf E; Barrow R; Yeo R; Lauriello J; Brooks WM
    Am J Psychiatry; 2005 Feb; 162(2):394-6. PubMed ID: 15677610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced auditory evoked gamma-band response and schizophrenia-like clinical symptoms under subanesthetic ketamine.
    Curic S; Leicht G; Thiebes S; Andreou C; Polomac N; Eichler IC; Eichler L; Zöllner C; Gallinat J; Steinmann S; Mulert C
    Neuropsychopharmacology; 2019 Jun; 44(7):1239-1246. PubMed ID: 30758327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subnormal sensory attenuation to self-generated speech in schizotypy: Electrophysiological evidence for a 'continuum of psychosis'.
    Oestreich LK; Mifsud NG; Ford JM; Roach BJ; Mathalon DH; Whitford TJ
    Int J Psychophysiol; 2015 Aug; 97(2):131-8. PubMed ID: 26027781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. S-Ketamine-Induced NMDA Receptor Blockade during Natural Speech Production and Its Implications for Formal Thought Disorder in Schizophrenia: A Pharmaco-fMRI Study.
    Nagels A; Cabanis M; Oppel A; Kirner-Veselinovic A; Schales C; Kircher T
    Neuropsychopharmacology; 2018 May; 43(6):1324-1333. PubMed ID: 29105665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ketamine Administration During the Second Postnatal Week Alters Synaptic Properties of Fast-Spiking Interneurons in the Medial Prefrontal Cortex of Adult Mice.
    Jeevakumar V; Kroener S
    Cereb Cortex; 2016 Mar; 26(3):1117-29. PubMed ID: 25477370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia.
    Gonzalez-Burgos G; Lewis DA
    Schizophr Bull; 2012 Sep; 38(5):950-7. PubMed ID: 22355184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients.
    Heresco-Levy U; Bar G; Levin R; Ermilov M; Ebstein RP; Javitt DC
    Schizophr Res; 2007 Mar; 91(1-3):14-21. PubMed ID: 17276036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain?
    Marek GJ; Behl B; Bespalov AY; Gross G; Lee Y; Schoemaker H
    Mol Pharmacol; 2010 Mar; 77(3):317-26. PubMed ID: 19933774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. General and emotion-specific neural effects of ketamine during emotional memory formation.
    Becker B; Steffens M; Zhao Z; Kendrick KM; Neumann C; Weber B; Schultz J; Mehta MA; Ettinger U; Hurlemann R
    Neuroimage; 2017 Apr; 150():308-317. PubMed ID: 28232170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
    D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
    Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studying auditory verbal hallucinations using the RDoC framework.
    Ford JM
    Psychophysiology; 2016 Mar; 53(3):298-304. PubMed ID: 26877116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synch before you speak: auditory hallucinations in schizophrenia.
    Ford JM; Roach BJ; Faustman WO; Mathalon DH
    Am J Psychiatry; 2007 Mar; 164(3):458-66. PubMed ID: 17329471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NMDA receptors, cognition and schizophrenia--testing the validity of the NMDA receptor hypofunction hypothesis.
    Gilmour G; Dix S; Fellini L; Gastambide F; Plath N; Steckler T; Talpos J; Tricklebank M
    Neuropharmacology; 2012 Mar; 62(3):1401-12. PubMed ID: 21420987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 40 Hz Auditory Steady-State Response Is a Pharmacodynamic Biomarker for Cortical NMDA Receptors.
    Sivarao DV; Chen P; Senapati A; Yang Y; Fernandes A; Benitex Y; Whiterock V; Li YW; Ahlijanian MK
    Neuropsychopharmacology; 2016 Aug; 41(9):2232-40. PubMed ID: 26837462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glutamatergic Deficits in Schizophrenia - Biomarkers and Pharmacological Interventions within the Ketamine Model.
    Haaf M; Leicht G; Curic S; Mulert C
    Curr Pharm Biotechnol; 2018; 19(4):293-307. PubMed ID: 29929462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The acute effects of NMDA antagonism: from the rodent to the human brain.
    Gunduz-Bruce H
    Brain Res Rev; 2009 May; 60(2):279-86. PubMed ID: 18703087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.